May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
In vitro Antibiotic Susceptibility of Ocular Isolates to Moxifloxacin, Gatifloxacin and Other Fluoroquinolones, São Paulo, Brazil
Author Affiliations & Notes
  • R. Belfort
    Ophthalmology Department, UNIFESP/EPM - Vision Institute, Sao Paulo, Brazil
  • A.L. Höfling-Lima
    Ophthalmology, UNIFESP/EPM, Sao Paulo, Brazil
  • B.C. Branco
    Ophthalmology, UNIFESP/EPM, Sao Paulo, Brazil
  • L.B. Sousa
    Ophthalmology, UNIFESP/EPM, Sao Paulo, Brazil
  • D. Freitas
    Ophthalmology, UNIFESP/EPM, Sao Paulo, Brazil
  • M.C. Yu
    Ophthalmology, UNIFESP/EPM, Sao Paulo, Brazil
  • Footnotes
    Commercial Relationships  R. Belfort, None; A.L. Höfling-Lima, None; B.C. Branco, None; L.B. Sousa, None; D. Freitas, None; M.C.Z. Yu, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 1468. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R. Belfort, A.L. Höfling-Lima, B.C. Branco, L.B. Sousa, D. Freitas, M.C. Yu; In vitro Antibiotic Susceptibility of Ocular Isolates to Moxifloxacin, Gatifloxacin and Other Fluoroquinolones, São Paulo, Brazil . Invest. Ophthalmol. Vis. Sci. 2003;44(13):1468.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:To assess the in-vitro susceptibility of conjunctival and corneal bacterial isolates from 154 patients to Moxifloxacin, Gatifloxacin, Ciprofloxacin and Ofloxacin. Methods: Fluoroquinolones disc diffusion antibiotic susceptibilities tests were performed for Staphylococcus coagulase negative (SCN), Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus viridans isolated from cornea and conjunctiva, and Pseudomonas aeruginosa from corneal samples. Results: Corneal isolates S. aureus, S. viridans and S. pneumoniae antibiotic susceptibilities were the same for all quinolones (100%). For SCN and Pseudomonas aeruginosa antibiotic susceptibility for Ciprofloxacin was 86% and 87% respectively and for Ofloxacin was 81 and 87% respectively. All corneal isolates were susceptible to Moxifloxacin and Gatifloxacin. The conjunctival isolated S. pneumoniae were susceptible to all quinolones. Ciprofloxacin had 90% and Ofloxacin 94% of efficacy against SCN isolates. S. aureus were 100% susceptible to Ciprofloxacin and Ofloxacin. S. viridans were 25% susceptible to Ciprofloxacin and 75% to Ofloxacin. All SCN, S. aureus and S. pneumoniae isolated from the conjunctiva were susceptible to Moxifloxacin. All SCN, S. aureus and S. pneumoniae as well as 75% of the S. viridans isolated from the conjunctiva were susceptible to Gatifloxacin. Conclusions: In this naive population to systemic or local Moxifloxacin and Gatifloxacin these antibiotics have shown better in vitro efficacy than previous generations fluoroquilonones. S. viridans resistance to Gatifloxacin was observed from conjunctival samples. Clinical correlation studies are under way to better understand its clinical significance.

Keywords: keratitis • keratoconus • microbial pathogenesis: clinical studies 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×